News Image

Prime Medicine Announces Additional Funding of Up to $24 Million from the Cystic Fibrosis Foundation to Advance Prime Editing Treatments for Cystic Fibrosis

Provided By GlobeNewswire

Last update: Jul 16, 2025

-- Expanded funding builds on the initial agreement to accelerate development of Prime Editors for Cystic Fibrosis (CF) --

-- Prime Medicine to receive up to $24 million in additional funding from the Cystic Fibrosis Foundation --

Read more at globenewswire.com

PRIME MEDICINE INC

NASDAQ:PRME (8/15/2025, 8:00:01 PM)

After market: 3.67 +0.1 (+2.8%)

3.57

-0.07 (-1.92%)



Find more stocks in the Stock Screener

Follow ChartMill for more